Shanghai Rongtai Health Technology Corp (603579.SS) Stock Price

Shanghai Rongtai Health Technology Corp Price

SSE·CLOSED
17.41CNY-0.62 (-3.50 %)
Market closed

Revenue has compounded at 13.1% per year over the past 11 years to 1.60 B CNY. Earnings per share have grown at 12.8% per year over the last 11 years. Shanghai Rongtai Health Technology Corp's net margin stands at 12.0%, up from 9.6% several years earlier. Shanghai Rongtai Health Technology Corp currently offers a dividend yield of about 6.14%. The payout ratio is around 110% of earnings. The dividend has grown at 8.6% per year over the past 7 years. Analysts set a median price target of 32.10 CNY, implying 84.4% above the current price. Of 6 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 8% above its 52-week low.

Shanghai Rongtai Health Technology Corp stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Shanghai Rongtai Health Technology Corp over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Shanghai Rongtai Health Technology Corp stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Shanghai Rongtai Health Technology Corp's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Shanghai Rongtai Health Technology Corp Stock Price History
DateShanghai Rongtai Health Technology Corp Price
8/24/202617.41 CNY
8/21/202618.03 CNY
8/20/202617.97 CNY
8/19/202618.09 CNY
8/18/202618.53 CNY
8/17/202618.52 CNY
8/14/202618.30 CNY
8/13/202618.50 CNY
8/12/202618.74 CNY
8/11/202618.46 CNY
8/10/202618.40 CNY
8/7/202618.35 CNY
8/6/202618.06 CNY
8/5/202618.04 CNY
8/4/202617.94 CNY
8/3/202617.93 CNY
7/31/202617.36 CNY
7/30/202617.52 CNY
7/29/202617.49 CNY
7/28/202617.59 CNY
7/27/202617.42 CNY
7/24/202616.30 CNY
7/23/202616.67 CNY
7/22/202616.06 CNY
7/21/202616.37 CNY
7/20/202616.51 CNY
7/17/202617.20 CNY
7/16/202617.77 CNY
7/15/202617.71 CNY
7/14/202617.47 CNY
7/13/202617.24 CNY
7/10/202617.82 CNY
7/9/202617.65 CNY
7/8/202617.95 CNY
7/7/202618.85 CNY
7/6/202619.00 CNY
7/3/202618.94 CNY
7/2/202618.14 CNY
7/1/202617.50 CNY
6/30/202616.97 CNY
6/29/202617.00 CNY
6/26/202616.81 CNY
6/25/202617.41 CNY
6/24/202618.56 CNY
6/23/202619.01 CNY
6/22/202619.41 CNY
6/18/202620.31 CNY
6/17/202619.04 CNY
6/16/202619.00 CNY
6/15/202619.27 CNY
6/12/202618.74 CNY
6/11/202618.19 CNY
6/10/202618.36 CNY
6/9/202618.69 CNY
6/8/202618.48 CNY
6/5/202618.90 CNY
6/4/202618.66 CNY
6/3/202619.29 CNY
6/2/202619.24 CNY
6/1/202619.41 CNY
5/29/202619.04 CNY
5/28/202619.09 CNY
5/27/202619.35 CNY
5/26/202620.02 CNY
5/25/202620.56 CNY
5/22/202620.98 CNY
5/21/202621.66 CNY
5/20/202621.60 CNY
5/19/202622.46 CNY
5/18/202621.96 CNY
5/15/202622.33 CNY
5/14/202621.66 CNY
5/13/202622.43 CNY
5/12/202622.28 CNY
5/11/202622.65 CNY
5/8/202623.00 CNY
5/7/202622.70 CNY
5/6/202622.45 CNY
4/30/202622.30 CNY
4/29/202622.15 CNY
4/28/202622.52 CNY
4/27/202622.08 CNY
4/24/202620.07 CNY
4/23/202620.07 CNY
4/22/202620.00 CNY
4/21/202620.02 CNY
4/20/202620.15 CNY
4/17/202620.03 CNY
4/16/202620.32 CNY
4/15/202620.11 CNY
4/14/202620.14 CNY
4/13/202620.06 CNY
4/10/202620.23 CNY
4/9/202620.01 CNY
4/8/202620.58 CNY
4/7/202619.91 CNY
4/3/202619.75 CNY
4/2/202620.07 CNY
4/1/202620.50 CNY
3/31/202619.85 CNY
3/30/202620.01 CNY
3/27/202619.97 CNY
3/26/202619.58 CNY
3/25/202620.03 CNY
3/24/202620.09 CNY
3/23/202619.32 CNY
3/20/202620.50 CNY
3/19/202621.80 CNY
3/18/202622.38 CNY
3/17/202622.03 CNY
3/16/202622.26 CNY
3/13/202622.17 CNY
3/12/202621.97 CNY
3/11/202622.27 CNY
3/10/202622.39 CNY
3/9/202621.90 CNY
3/6/202622.28 CNY
3/5/202622.08 CNY
3/4/202621.75 CNY
3/3/202622.40 CNY
3/2/202623.16 CNY
2/27/202624.25 CNY
2/26/202624.21 CNY
2/25/202624.71 CNY
2/24/202624.31 CNY
2/13/202624.26 CNY
2/12/202624.28 CNY
2/11/202624.35 CNY
2/10/202624.72 CNY
2/9/202625.30 CNY
2/6/202624.95 CNY
2/5/202624.71 CNY
2/4/202624.71 CNY
2/3/202624.39 CNY
2/2/202624.02 CNY
1/30/202624.25 CNY
1/29/202624.84 CNY
1/28/202625.16 CNY
1/27/202625.05 CNY
1/26/202625.50 CNY
1/23/202626.84 CNY
1/22/202626.97 CNY
1/21/202626.65 CNY
1/20/202626.41 CNY
1/19/202626.25 CNY
1/16/202626.63 CNY
1/15/202627.71 CNY
1/14/202627.62 CNY
1/13/202627.29 CNY
1/12/202627.99 CNY
1/9/202627.55 CNY
1/8/202627.25 CNY
1/7/202626.82 CNY
1/6/202628.81 CNY
1/5/202626.19 CNY
12/31/202523.81 CNY
12/30/202523.44 CNY
12/29/202523.54 CNY
12/26/202523.37 CNY
12/25/202523.81 CNY
12/24/202523.21 CNY
12/23/202523.05 CNY
12/22/202523.42 CNY
12/19/202523.60 CNY
12/18/202523.71 CNY
12/17/202522.66 CNY
12/16/202522.38 CNY
12/15/202522.89 CNY
12/12/202522.97 CNY
12/11/202522.98 CNY
12/10/202523.60 CNY
12/9/202523.53 CNY
12/8/202523.79 CNY
12/5/202523.69 CNY
12/4/202523.53 CNY
12/3/202523.73 CNY
12/2/202524.16 CNY
12/1/202524.30 CNY
11/28/202524.22 CNY
11/27/202524.43 CNY
11/26/202524.28 CNY
11/25/202524.58 CNY
11/24/202524.43 CNY
11/21/202523.85 CNY
11/20/202524.71 CNY
11/19/202524.83 CNY
11/18/202525.58 CNY
11/17/202525.89 CNY
11/14/202525.80 CNY
11/13/202525.93 CNY
11/12/202526.16 CNY
11/11/202526.14 CNY
11/10/202526.45 CNY
11/7/202526.48 CNY
11/6/202526.93 CNY
11/5/202526.88 CNY
11/4/202528.57 CNY
11/3/202529.88 CNY
10/31/202530.11 CNY
10/30/202529.80 CNY
10/29/202533.11 CNY
10/28/202531.90 CNY
10/27/202531.31 CNY
10/24/202531.17 CNY
10/23/202530.93 CNY
10/22/202531.46 CNY
10/21/202531.84 CNY
10/20/202531.88 CNY
10/17/202531.88 CNY
10/16/202533.10 CNY
10/15/202532.80 CNY
10/14/202531.06 CNY
10/13/202531.29 CNY
10/10/202533.41 CNY
10/9/202533.35 CNY
9/30/202534.50 CNY
9/29/202535.35 CNY
9/26/202534.86 CNY
9/25/202536.99 CNY
9/24/202536.31 CNY
9/23/202534.97 CNY
9/22/202536.67 CNY
9/19/202536.79 CNY
9/18/202539.05 CNY
9/17/202540.00 CNY
9/16/202538.85 CNY
9/15/202535.32 CNY
9/12/202535.93 CNY
9/11/202536.95 CNY
9/10/202535.29 CNY
9/9/202534.28 CNY
9/8/202537.80 CNY
9/5/202538.30 CNY
9/4/202537.35 CNY
9/3/202539.30 CNY
9/2/202540.02 CNY
9/1/202537.80 CNY
8/29/202537.02 CNY
8/28/202537.51 CNY
8/27/202537.28 CNY
Access this data via the Eulerpool API
Get Free API Key

Shanghai Rongtai Health Technology Corp Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
2.61 B CNY
198.95 M CNY
236.34 M CNY
Jan 1, 2022
2.00 B CNY
134.64 M CNY
164.23 M CNY
Jan 1, 2023
1.86 B CNY
209.77 M CNY
202.71 M CNY
Jan 1, 2024
1.60 B CNY
161.63 M CNY
191.95 M CNY
Jan 1, 2025 (e)
1.59 B CNY
260.80 M CNY
168.20 M CNY
Jan 1, 2026 (e)
1.79 B CNY
293.12 M CNY
174.14 M CNY
Jan 1, 2027 (e)
1.98 B CNY
323.47 M CNY
199.86 M CNY
Jan 1, 2028 (e)
2.16 B CNY
353.16 M CNY
231.52 M CNY

Shanghai Rongtai Health Technology Corp Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 3:53 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
2013201420152016201720182019202020212022202320242025e2026e2027e2028e
0.410.721.021.291.922.302.312.022.612.001.861.601.591.791.982.16
–75.9141.6325.4949.1819.720.78-12.6729.31-23.28-7.44-13.96-0.1312.3610.339.21
27.0130.2932.3237.9038.0833.9431.0028.5626.7626.3530.5131.4531.4531.4531.4531.45
111.00219.00331.00487.00730.00779.00717.00577.00699.00528.00566.00502.00501.37563.33621.52678.77
22.0070.00145.00209.00289.00330.00280.00201.00198.00134.00209.00161.00260.00293.00323.00353.00
5.359.6814.1616.2615.0814.3812.119.957.586.6911.2710.0916.3116.3616.3516.36
25.0061.00142.00206.00216.00249.00295.00193.00236.00164.00202.00191.00168.00174.00199.00231.00
–144.00132.7945.074.8515.2818.47-34.5822.28-30.5123.17-5.45-12.043.5714.3716.08
––––0.600.800.461.500.500.700.501.070.700.780.87–
–––––33.33-42.50226.09-66.6740.00-28.57114.00-34.5811.4311.54–
100.00105.00105.00105.00136.80140.00138.80136.90181.80173.57179.26197.88197.88197.88197.88197.88
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Shanghai Rongtai Health Technology Corp generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Shanghai Rongtai Health Technology Corp retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Shanghai Rongtai Health Technology Corp's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Shanghai Rongtai Health Technology Corp has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Shanghai Rongtai Health Technology Corp's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Shanghai Rongtai Health Technology Corp stock margins

The Shanghai Rongtai Health Technology Corp margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Shanghai Rongtai Health Technology Corp. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Shanghai Rongtai Health Technology Corp.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
28.57 %
9.97 %
9.55 %
Jan 1, 2021
26.79 %
7.62 %
9.05 %
Jan 1, 2022
26.36 %
6.72 %
8.19 %
Jan 1, 2023
30.53 %
11.31 %
10.93 %
Jan 1, 2024
31.44 %
10.12 %
12.02 %
Jan 1, 2025 (e)
31.44 %
16.36 %
10.55 %
Jan 1, 2026 (e)
31.44 %
16.36 %
9.72 %
Jan 1, 2027 (e)
31.44 %
16.36 %
10.11 %

Shanghai Rongtai Health Technology Corp Stock Revenue, EBIT, Earnings per Share

The Shanghai Rongtai Health Technology Corp earnings per share therefore indicates how much revenue Shanghai Rongtai Health Technology Corp has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
14.76 CNY
1.47 CNY
1.41 CNY
Jan 1, 2021
14.37 CNY
1.09 CNY
1.30 CNY
Jan 1, 2022
11.55 CNY
0.78 CNY
0.95 CNY
Jan 1, 2023
10.35 CNY
1.17 CNY
1.13 CNY
Jan 1, 2024
8.07 CNY
0.82 CNY
0.97 CNY
Jan 1, 2025 (e)
8.06 CNY
1.32 CNY
0.85 CNY
Jan 1, 2026 (e)
9.05 CNY
1.48 CNY
0.88 CNY
Jan 1, 2027 (e)
9.99 CNY
1.63 CNY
1.01 CNY

Shanghai Rongtai Health Technology Corp business model & stock analysis

Shanghai Rongtai Health Technology Corp Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Shanghai Rongtai Health Technology Corp historical P/E ratio, EBIT multiple, and P/S ratio

Shanghai Rongtai Health Technology Corp annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Shanghai Rongtai Health Technology Corp shares outstanding

The number of shares of Shanghai Rongtai Health Technology Corp was 197.88 M in 2025. This indicates how many shares Shanghai Rongtai Health Technology Corp is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
136.90 M Stocks
Jan 1, 2021
181.80 M Stocks
Jan 1, 2022
173.57 M Stocks
Jan 1, 2023
179.26 M Stocks
Jan 1, 2024
197.88 M Stocks
Jan 1, 2025 (e)
197.88 M Stocks
Jan 1, 2026 (e)
197.88 M Stocks
Jan 1, 2027 (e)
197.88 M Stocks

Shanghai Rongtai Health Technology Corp stock splits

In Shanghai Rongtai Health Technology Corp's history, there have been no stock splits.

Shanghai Rongtai Health Technology Corp Dividend History

10 years of dividend payments

YearAnnual DividendYoY ChangePayments
20260.50CNYYTD—1×
Jun 10, 20260.50CNY↑ 42.9%1/1
20250.35CNY↓ 67.3%1×
Jun 12, 20250.35CNY↑ 16.7%1/1
20241.07CNY↑ 113.8%2×
20230.50CNY↓ 28.6%1×
20220.70CNY↑ 40.0%1×
20210.50CNY↓ 66.7%1×
20201.50CNY↑ 400.0%1×
20190.30CNY↓ 62.5%1×
20180.80CNY↑ 33.3%2×
20170.60CNY—1×

Shanghai Rongtai Health Technology Corp dividend history and estimates

In 2025, Shanghai Rongtai Health Technology Corp paid a dividend amounting to 0.35 CNY. Dividend means that Shanghai Rongtai Health Technology Corp distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
1.50 CNY
0.00 CNY
Jan 1, 2021
0.50 CNY
0.00 CNY
Jan 1, 2022
0.70 CNY
0.00 CNY
Jan 1, 2023
0.50 CNY
0.00 CNY
Jan 1, 2024
1.07 CNY
0.00 CNY
Jan 1, 2025 (e)
0.35 CNY
0.35 CNY
Jan 1, 2026 (e)
0.00 CNY
0.78 CNY
Jan 1, 2027 (e)
0.00 CNY
0.87 CNY

Shanghai Rongtai Health Technology Corp dividend payout ratio

In 2025, Shanghai Rongtai Health Technology Corp had a payout ratio of 82.35%. The payout ratio indicates the percentage of the company's profits that Shanghai Rongtai Health Technology Corp distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
81.83 %
Jan 1, 2021
29.58 %
Jan 1, 2022
56.91 %
Jan 1, 2023
34.01 %
Jan 1, 2024
110.23 %
Jan 1, 2025 (e)
82.35 %
Jan 1, 2026 (e)
88.84 %
Jan 1, 2027 (e)
86.45 %

Current Shanghai Rongtai Health Technology Corp forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
66.67 % (4)
Hold
33.33 % (2)
Sell
0.00 % (0)
12M Price Target
32.10
Last Price
17.41
Currency
CNY
12M Return Potential
84.37 %
LTM Return
0 %

Shanghai Rongtai Health Technology Corp shareholder structure

% Name
22.92792%
Lin (Qi)
Lin (Qi)
14.12447%
Lin (Guangrong)
Lin (Guangrong)
6.43837%
Kai'en New Energy Private Fund
Kai'en New Energy Private Fund
4.73008%
Lin (Jue)
Lin (Jue)
1.83948%
Shanghai Crassets Investment Management Co., Ltd
Shanghai Crassets Investment Management Co., Ltd
1.05130%
Shanghai Rongtai Health Technology Co., Ltd. - 2021 Mgmt Partner SOP
Shanghai Rongtai Health Technology Co., Ltd. - 2021 Mgmt Partner SOP

Shanghai Rongtai Health Technology Corp Beneficial Ownership Filings (SEC 13D/G)

Free Float
55.4%
Float Shares
-
Shares Outstanding
-

Shanghai Rongtai Health Technology Corp Executives and Management Board

13 members · avg. age 52 · 23 % women

JK

Mr. Jian Kong (47)

Deputy General Manager

916,700.00 CNY

QL

Mr. Qi Lin (46)

General Manager, Director

1.05 M CNY
BZ

Mr. Bo Zhang (49)

Secretary of the Board, Director

826,400.00 CNY
JW

Mr. Junliang Wang (45)

Deputy General Manager, Director

796,000.00 CNY
GL

Mr. Guangrong Lin (75)

Chairman of the Board

772,400.00 CNY
JW

Ms. Jiafen Wang (71)

Director

478,700.00 CNY
XW

Mr. Xiaogang Wu (43)

Director

474,500.00 CNY

Shanghai Rongtai Health Technology Corp Supply Chain

Shanghai Rongtai Health Technology Corp Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
5 companies
#NameTrend
1
Alibaba Group Holding
Supplier·Customer·CN
0.23
-0.01
0.59
0.61
0.75
0.56
2
Xiaomi B
Supplier·Customer·Technology Hardware, Storage & Peripherals·CN
0.04
-0.38
0.84
0.91
0.80
0.42
3
Amazon.com
Supplier·Customer·Internet & Direct Marketing Retail·US
-0.11
-0.52
0.25
0.52
0.57
0.35
#NameTrend
1
Suning com A
Supplier·Customer·Specialty Retail·CN
0.63
-0.39
0.69
0.88
0.81
—
2
JD com A
Supplier·Customer·Internet & Direct Marketing Retail·CN
0.06
-0.46
0.72
0.75
0.47
—

Frequently asked questions about Shanghai Rongtai Health Technology Corp

Analysts currently set an average price target of 32.10 CNY for the Shanghai Rongtai Health Technology Corp stock (median: 32.10 CNY), implying +84.4 % versus the latest price. The consensus is based on 6 analyst ratings.

Shanghai Rongtai Health Technology Corp Analyst Price Targets 2026

6 analysts currently rate the Shanghai Rongtai Health Technology Corp stock: 4 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Shanghai Rongtai Health Technology Corp to generate revenue of 1.79 B CNY and earnings per share of 0.88 CNY.

Shanghai Rongtai Health Technology Corp Analyst Price Targets 2026

Converted at the current exchange rate, the Shanghai Rongtai Health Technology Corp share trades at 2.22 EUR (17.41 CNY).

No history available for Shanghai Rongtai Health Technology Corp.

The expected revenue of Shanghai Rongtai Health Technology Corp is 1.79 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Shanghai Rongtai Health Technology Corp is 174.14 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Shanghai Rongtai Health Technology Corp is currently 19.78. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Shanghai Rongtai Health Technology Corp stock.

The price-to-sales ratio (P/S) of Shanghai Rongtai Health Technology Corp is currently 1.92. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Shanghai Rongtai Health Technology Corp stock.

The Eulerpool Quality Score for Shanghai Rongtai Health Technology Corp is 5/10.

The ISIN of Shanghai Rongtai Health Technology Corp is CNE100002R81. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Shanghai Rongtai Health Technology Corp is 603579.SS. The ticker symbol is used to trade Shanghai Rongtai Health Technology Corp shares on the stock exchange.

Over the past 12 months, Shanghai Rongtai Health Technology Corp paid a dividend of 1.07 CNY . This corresponds to a dividend yield of about 6.14 %. For the coming 12 months, Shanghai Rongtai Health Technology Corp is expected to pay a dividend of 0.87 CNY.

The current dividend yield of Shanghai Rongtai Health Technology Corp is 6.14 %.

Shanghai Rongtai Health Technology Corp pays a dividend, distributed in the months of , , , .

Shanghai Rongtai Health Technology Corp paid dividends every year for the past 9 years.

For the upcoming 12 months, dividends amounting to 0.87 CNY are expected. This corresponds to a dividend yield of 5.01 %.

Shanghai Rongtai Health Technology Corp is assigned to the 'Cyclical consumption' sector.

In the year 2025, Shanghai Rongtai Health Technology Corp distributed 1.07 CNY as dividends.

The dividends of Shanghai Rongtai Health Technology Corp are distributed in CNY.

All fundamentals and in-depth analysis of Shanghai Rongtai Health Technology Corp

Our stock analysis for Shanghai Rongtai Health Technology Corp stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Rongtai Health Technology Corp. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Revenue→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Net Income→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp P/E→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp P/S→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp EBIT→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Dividend→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Directors Dealings→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Stocks→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Market capitalization→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Debt→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Liabilities→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Equity→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp AAQS→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Employees→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp ROE→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp ROA→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp ROCE→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp News→
Shanghai Rongtai Health Technology Corp Stock
Shanghai Rongtai Health Technology Corp Analyst Price Targets→

Cyclical consumption Stocks

Shanghai Sanmao Enterprise Group CoShanghai Phoenix Enterprise Group CoShanghai Shenda CoShanghai Metersbonwe Fashion&Accessories CoShanghai Shuixing Home Textile CoShanghai Lily & Beauty Cosmetics CoShanghai Sinotec CoShanghai Lianming Machinery CoShanghai SK Automation Technology CoShanghai Kaytune Industrial CoShanghai Vico Precision Mold & Plastics CoShanghai Join Buy CoAll Stocks A–Z →